Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001677301-16-000001
Filing Date
2016-06-21
Accepted
2016-06-21 19:30:24
Documents
1
Period of Report
2016-06-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3298
  Complete submission text file 0001677301-16-000001.txt   4888
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807
Business Address
ROBERTSON RUSSEL C (Reporting) CIK: 0001677301 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14956 | Film No.: 161725413